Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma.
Elias Karl MaiThomas HielscherUta BertschJana SchlenzkaHans J SalwenderMarkus MunderChristian GereckeUlrich DührsenPeter BrossartKai NebenJens HillengassMarc S RaabMaximilian MerzMarc-Andrea BaertschAnna JauchDirk HoseHans MartinHans-Walter LindemannIgor W BlauChristof ScheidKatja C WeiselHartmut Goldschmidtnull nullPublished in: Leukemia (2018)